Global Bioabsorbable Stents Market Comprehensive Study: Forecasted Market Size And Growth Rate | Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical Inc., Tepha Inc.

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Bioabsorbable Stents Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The bioabsorbable stents market size has grown rapidly in recent years. It will grow from $0.35 billion in 2023 to $0.38 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, growing demand for minimally invasive procedures, increasing awareness of bioabsorbable stents, rising disposable incomes, industry investments.

The bioabsorbable stents market size is expected to see strong growth in the next few years. It will grow to $0.55 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to expanded clinical indications, customization and personalization, global expansion, patient-friendly option. Major trends in the forecast period include advancements in bioabsorbable materials, clinical advancements, clinical data and research, hybrid stent designs, longer absorption periods, collaborations and partnerships.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

Market Segmentation:
The main products of bioabsorbable stents are polymer-based bioabsorbable stents and metal-based bioabsorbable stents. Bioresorbable stents (BRS) or vascular scaffolds are coronary stents that can fully dissolve in the body. It is also segmented by absorption rate into slow-absorption stents and fast-absorption that are used in various applications such as coronary artery diseases, and peripheral artery diseases.

Major Driver - Rising Cardiovascular Disease Rates Propel Growth In The Bioabsorbable Stents Market
Increasing cardiovascular diseases is a key factor driving the growth of the bioabsorbable stents market. Cardiovascular disorders are the leading cause of death across the world and 4 out of 5 cardiovascular deaths are caused by strokes and heart attacks. Moreover, one-third of such deaths occur prematurely in people under the age of 70. Bioresorbable stents are built primarily to reduce these risks of late complications, such as scaffold thrombosis or restenosis, that can happen when a conventional metal stent's rigid metal backbone remains permanently rooted in the diseased vessel. According to the American Heart Association, it is estimated that more than 23.6 million die due to cardiovascular diseases by 2030. Therefore, increasing cardiovascular diseases are expected to drive the bioabsorbable stents industry.

Competitive Landscape:
Major companies operating in the bioabsorbable stents market include Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical Inc., Tepha Inc., S3V Vascular Technologies, ICON Interventional Systems Inc., Arterius Limited, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Medlogics Device Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard Inc., Stentys SA, Terumo Corporation, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt Ltd., Eurocor GmbH, Hexacath, Kyoto Medical Planning Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Medtronic Inc., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Sinomed, Surmodics Inc., Translumina Therapeutics, Vascular Concepts Limited, Xenogenics Corporation

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Top Trend - Drug-Eluting Stents Take Center Stage In The Bioabsorbable Stents Market
The drug-eluting stent (DES) is gaining significant popularity in the bioabsorbable stents market. The drug-eluting stent (DES) device was designed to avoid the regeneration of tissue that would otherwise obstruct the artery and this was a new step forward in the treatment of peripheral artery disease. Boston Scientific launched its self-expanding drug-eluting stent (DES) peripheral artery disease (PAD) scheme which helped the company to expand its PAD portfolio.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Bioabsorbable Stents Market Characteristics
3. Bioabsorbable Stents Market Trends And Strategies
4. Bioabsorbable Stents Market - Macro Economic Scenario
5. Bioabsorbable Stents Market Size And Growth
…..
27. Bioabsorbable Stents Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.